| 20 Health - Lou Gehrig's disease - Amyotrophic Lateral Sclerosis (ALS) Resources |
| ALS Aggregates Are Composed Of Only One Protein
|
| Researchers have provided a big new clue to help combat amyotrophic lateral sclerosis (ALS), deciphering that the dense protein aggregates that contribute to the nerve decay of ALS are composed of just one protein: superoxide dismutase (SOD1).
|
| Open |
Open Tab |
March 31, 2008 |
Provides Information |
| C |
| Chemical Exposure May Increase Risk Of ALS, Study Shows
|
| Preliminary results show that a common environmental chemical may increase the risk of developing amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, according to new research.
|
| Open |
Open Tab |
April 17, 2008 |
Provides Information |
| D |
| Discovery of new ALS gene
|
| The ALS research team at Umea University in Sweden, working with Dutch and Belgian colleagues, has found new connections between mutations in gene DPP6 and contracting the non-hereditary form of ALS. The findings are being published december 16 in Nature Genetics on the Web.
|
| Open |
Open Tab |
December 19, 2007 |
Provides Information |
| Discovery Offers Hope Of Halting ALS Progression
|
| Scientists have discovered a causal link between the gene for a small protein involved in the formation of blood vessels and the development of some forms of Motor Neurone Disease.
|
| Open |
Open Tab |
October 7, 2007 |
Provides Information |
| G |
| Genes That Improve Survival In Mice With ALS Identified
|
| University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
|
| Open |
Open Tab |
September 17, 2007 |
Provides Information |
| L |
| Lithium slows ALS progression
|
| Daily doses of lithium, a drug used to treat bipolar disorder, have been found to delay progression of amyotrophic lateral sclerosis (ALS) in an Italian study of 44 people with the disease.
|
| Open |
Open Tab |
February 4, 2008 |
Provides Information |
| M |
| Many ALS Patients Have High Quality Of Life
|
| Patients with amyotrophic lateral sclerosis (ALS) experience an astonishingly high quality of life. This disease leads to progressive muscular weakness and the clinical course is always fatal. In spite of the continuously increasing loss of control, studies performed by Birbaumer et al. (Tübingen) and Ludolph et al. (Ulm) and reported in the current edition of Deutsches Ärzteblatt International have shown that many ALS patients are satisfied with their lives.
|
| Open |
Open Tab |
June 24, 2008 |
Provides Information |
| Mutation in TDP-43 gene may play role in common dementia
|
| Scientists at Washington University School of Medicine in St. Louis have linked a mutation in a gene known as TDP-43 to an inherited form of amyotrophic lateral sclerosis (ALS), the neurodegenerative condition often called Lou Gehrig's disease.
|
| Open |
Open Tab |
February 21, 2008 |
Provides Information |
| N |
| Nanotechnology Allows Identification of Peptide "Fingerprint" in Both Forms of Amyotrophic Lateral Sclerosis (ALS)
|
| A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
|
| Open |
Open Tab |
September 11, 2007 |
Provides Information |
| Nanotechnology Helps Identify Amyotrophic Lateral Sclerosis or ALS
|
| A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
|
| Open |
Open Tab |
September 5, 2007 |
Provides Information |
| Nanotechnology helps identify molecular signature common to Lou Gehrig's disease
|
| A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
|
| Open |
Open Tab |
September 5, 2007 |
Provides Information |
| Nanotechnology Identifies Peptide 'Fingerprint' In Both Forms Of ALS
|
| A nanotechnology developed by a University at Buffalo professor has enabled researchers to identify a molecular signature common to both familial and sporadic cases of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
|
| Open |
Open Tab |
September 16, 2007 |
Provides Information |
| New insight into the genetics of Lou Gehrig's disease
|
| An upcoming paper from Drs. Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) and colleagues lends new and valuable insight into the genetics of ALS.
|
| Open |
Open Tab |
June 1, 2008 |
Provides Information |
| New insight into the mechanisms of Lou Gehrig's disease
|
| There is no known cure for amyotrophic lateral sclerosis (ALS), often known as Lou Gehrig disease and motor neuron disease.
|
| Open |
Open Tab |
September 14, 2007 |
Provides Information |
| R |
| Risk Of ALS Exposure In Gulf War Veterans Is Time Limited
|
| A new study, led by researchers at the University of Cincinnati (UC), says that cases of Amyotrophic Lateral Sclerosis (ALS) among soldiers who served in the first Persian Gulf War were caused by certain events during their deployment to the war zone, meaning the exposure and illness is not as widespread as previously thought.
|
| Open |
Open Tab |
June 10, 2008 |
Provides Information |
| S |
| Study Shows Antibiotic Harms ALS Patients
|
| A trial of the antibiotic minocycline against amyotrophic lateral sclerosis -- Lou Gehrig's disease -- has been halted because patients taking the drug had a significantly accelerated decline in neurological function.
|
| Open |
Open Tab |
November 1, 2007 |
Provides Information |
| U |
| Umbilical Cord Blood Cell Transplants May Help ALS Patients
|
| A study at the University of South Florida has shown that transplants of mononuclear human umbilical cord blood (MNChUCB) cells may help patients suffering from Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease.
|
| Open |
Open Tab |
June 26, 2008 |
Provides Information |
| Unexpected protein-protein interaction suggests new ALS drug target
|
| Discovery of an unexpected protein-protein interaction has led University of Iowa scientists and colleagues to identify a drug that slows the progression of Amyotrophic Lateral Sclerosis (ALS) in mice and nearly doubles the animals' lifespan.
|
| Open |
Open Tab |
January 28, 2008 |
Provides Information |
| Y |
| Yeast Has Potential For Selecting Lou Gehrig's Disease Drugs
|
| Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease -- using yeast cells. In recent months a number of mutations have been found in a disease protein called TDP-43, which is implicated in ALS and certain types of frontotemporal dementia (FTD).
|
| Open |
Open Tab |
April 21, 2008 |
Provides Information |